These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33815793)

  • 21. Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy.
    Takezako N; Sekiguchi N; Nagata A; Homma C; Takezako Y; Noto S; Natori K; Miwa A
    Thromb Res; 2015 Jul; 136(1):20-3. PubMed ID: 25934464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
    Takahashi H; Ebihara S; Okazaki T; Asada M; Sasaki H; Yamaya M
    Br J Pharmacol; 2005 Oct; 146(3):333-43. PubMed ID: 16041398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated intravascular coagulation. Approach to treatment.
    Rubin RN; Colman RW
    Drugs; 1992 Dec; 44(6):963-71. PubMed ID: 1282866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
    Koseki M; Asada N; Uryu H; Takeuchi M; Asakura H; Matsue K
    Int J Hematol; 2007 Dec; 86(5):403-6. PubMed ID: 18192107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful anticoagulant therapy for disseminated intravascular coagulation during conservative management of placenta percreta: a case report and literature review.
    Matsuzaki S; Yoshino K; Endo M; Tomimatsu T; Takiuchi T; Mimura K; Kumasawa K; Ueda Y; Kimura T
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):443. PubMed ID: 29284430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minidose heparin therapy. Treatment of chronic intravascular coagulation syndrome.
    Diskin CJ; Weitberg AB
    Arch Intern Med; 1980 Feb; 140(2):263-6. PubMed ID: 7352823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disseminated intravascular coagulation related to atherosclerosis and aneurysm of aorta: successful management with subcutaneous self injection of heparin sodium].
    Takahashi K; Ichikawa Y; Arimori S
    Rinsho Ketsueki; 1989 Oct; 30(10):1820-5. PubMed ID: 2593249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
    Minakata D; Fujiwara SI; Hayakawa J; Nakasone H; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Ishihara Y; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Acta Haematol; 2020; 143(3):250-259. PubMed ID: 31461700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
    World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
    Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
    Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disseminated intravascular coagulation].
    Iba T; Kidokoro A
    Nihon Rinsho; 2003 Jun; 61(6):1010-4. PubMed ID: 12806952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.
    Aoki N; Matsuda T; Saito H; Takatsuki K; Okajima K; Takahashi H; Takamatsu J; Asakura H; Ogawa N;
    Int J Hematol; 2002 Jun; 75(5):540-7. PubMed ID: 12095157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature.
    Takeyama H; Sakiyama T; Wakasa T; Kitani K; Inoue K; Kato H; Ueda S; Tsujie M; Fujiwara Y; Yukawa M; Ohta Y; Inoue M
    Oncol Lett; 2017 Jun; 13(6):4290-4294. PubMed ID: 28599429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
    Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
    Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
    J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and management of DIC complicated by hematological malignancies].
    Ikezoe T
    Rinsho Ketsueki; 2016; 57(10):2136-2144. PubMed ID: 27795523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To be or not to be a case of heparin resistance.
    Durrani J; Malik F; Ali N; Jafri SIM
    J Community Hosp Intern Med Perspect; 2018; 8(3):145-148. PubMed ID: 29915655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.